Ubatay, Marife M.
HRN: 20-39-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CEFUROXIME 500MG (TAB)
03/09/2024
03/16/2024
PO
500mg
BID
S/P Cervical Polypectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes